Product
HemAssist
HemAssist is an early hemoglobin-based oxygen carrier (HBOC) product that encountered setbacks in clinical trials due to serious adverse events such as vasoconstriction and myocardial infarction.
Timeline (last 90 days)
Oct 14
Early HBOC products such as HemAssist and PolyPheme showed serious adverse events including vasoconstriction and myocardial infarction in clinical trials, mainly because free hemoglobin scavenges nitric oxide, causing abnormal vascular tone.
Unverified50%